Medicines regulators set out priorities for next five yearsMedicines regulators across Europe have set out their priorities for the next five years in a proposed strategy now out for consultation.…
Untapped cost-efficiencies are a barrier to drugs access ‘in Europe and beyond’, says WHO A lack of collaboration and pharmacoeconomic analysis is hampering processes aimed at ensuring sustainable access to new drugs in Europe, says the World Health Organization.…
EMA fast tracks approval of thyroid cancer drugThe European Medicines Agency is recommending that Lenvima (lenvatinib) be available across Europe for the treatment of some patients with thyroid cancer.…
Promoting medical innovation as a pharmaceutical scientist Zahid Latif has worked in drug discovery projects across the UK and now leads efforts to promote innovative medical research collaborations between industry and academia.…
Analysts predict surge in ‘blockbuster drugs’ entering the market in 2015Over the next twelve months there will be 11 “blockbuster” drugs entering the market, according to business intelligence company Thomson Reuters.…
FDA approves cholic acid for rare bile acid synthesis disordersCholic acid, a drug used to treat bile acid synthesis disorders and peroxisomal disorders, has been approved by the US Food and Drug Administration.…
How changes to UK flexible working laws affect pharmacists Kevin McKenna, head of employment law at Kuits Solicitors in Manchester, explains how changes to laws on flexible working have affected employers and employees.…
Pharmacists are in a good position to make the move into industry Pharmacists should value the mix of clinical and scientific knowledge that makes them an asset within industry.…
The secret life of ketamine Ketamine is being used to treat depression in clinics that are springing up across the United States, but uncertainty remains over its long-term use.…